desipramine has been researched along with Hypercapnia in 1 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Hypercapnia: A clinical manifestation of abnormal increase in the amount of carbon dioxide in arterial blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, X | 1 |
| Su, J | 1 |
| Cui, N | 1 |
| Gai, H | 1 |
| Wu, Z | 1 |
| Jiang, C | 1 |
1 other study available for desipramine and Hypercapnia
| Article | Year |
|---|---|
The disruption of central CO2 chemosensitivity in a mouse model of Rett syndrome.
Topics: Action Potentials; Animals; Carbon Dioxide; Chemoreceptor Cells; Desipramine; Disease Models, Animal | 2011 |